Response Evaluation Using 68 Ga-DOTA-IBA in a Case of Metastatic Prostate Cancer.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 39853189.
- Also identified by DOI 10.1097/RLU.0000000000005666.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
We report a case of a patient with metastatic prostate cancer receiving first-line endocrine therapy. Clinical symptoms, PSA level, and CT confirmed the significant progression of his bone metastatic lesions. In comparison to images at baseline, follow-up bone scan incorrectly showed remission of the bone lesions, whereas follow-up 68 Ga-DOTA-IBA correctly showed disease progression.
Medical subject headings
- Prostatic Neoplasms
- Organometallic Compounds